Correlation Between GRI Bio and Werewolf Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GRI Bio and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GRI Bio and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GRI Bio and Werewolf Therapeutics, you can compare the effects of market volatilities on GRI Bio and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GRI Bio with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GRI Bio and Werewolf Therapeutics.

Diversification Opportunities for GRI Bio and Werewolf Therapeutics

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between GRI and Werewolf is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding GRI Bio and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and GRI Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GRI Bio are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of GRI Bio i.e., GRI Bio and Werewolf Therapeutics go up and down completely randomly.

Pair Corralation between GRI Bio and Werewolf Therapeutics

Considering the 90-day investment horizon GRI Bio is expected to under-perform the Werewolf Therapeutics. In addition to that, GRI Bio is 1.28 times more volatile than Werewolf Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Werewolf Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest  148.00  in Werewolf Therapeutics on November 1, 2024 and sell it today you would lose (13.50) from holding Werewolf Therapeutics or give up 9.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GRI Bio  vs.  Werewolf Therapeutics

 Performance 
       Timeline  
GRI Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GRI Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Etf's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the Etf traders.
Werewolf Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Werewolf Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

GRI Bio and Werewolf Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GRI Bio and Werewolf Therapeutics

The main advantage of trading using opposite GRI Bio and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GRI Bio position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.
The idea behind GRI Bio and Werewolf Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes